Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

Objective: the aim of the study was to evaluate the efficacy of continuous positive airway
pressure (CPAP) for the treatment of obstructive sleep apnea in the elderly. Method: a …

Obstructive sleep apnea (OSA) is a rather common chronic disorder, associated with
increased prevalence of hypertension. The pathophysiological mechanisms for …

Study objective To synthesize evidence from available studies on the relative efficacies of
continuous positive airway pressure (CPAP), mandibular advancement device (MAD) …

Almost one billion individuals worldwide suffer from obstructive sleep apnea (OSA). The
most widely used treatment for OSA has been continuous positive airway pressure (CPAP) …

Background Continuous positive airway pressure (CPAP) is the first-line therapy for
obstructive sleep apnea (OSA), but patient compliance is a major barrier to long-term …

Background: This meta-analysis assessed the effect of long-term (> 6 weeks) noninvasive
positive airway pressure (PAP) on diastolic function in patients with obstructive sleep apnea …

This meta-analysis was performed to determine the effects of continuous positive airway
pressure (CPAP) on blood pressure (BP) in patients with systemic hypertension and …

Obstructive sleep apnea (OSA) is an extremely common comorbid condition in patients with
hypertension, with a prevalence of~ 50%. There is growing evidence suggesting that OSA is …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …